Skip to content

Haritakyadi kwatha pana and kokila varti anjana in Diabetic Retinopathy

A Randomized clinical trial to compare the efficacy of Haritakyadi Kwatha Pana And Kokila Varti Anjana with and without Yogic therapy in Madhumehajanya Timira W.S.R to Diabetic Retinopathy - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/04/084536
Enrollment
40
Registered
2025-04-11
Start date
Unknown
Completion date
Unknown
Last updated
2025-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H352- Other non-diabetic proliferative retinopathy

Interventions

None listed

Sponsors

Shri Vijay Mahantesh Ayurvedic Medical College IKAL
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients who are fit for Anjana karma are included with features of Non-proliferative Diabetic Retinopathy. 2. Patients of Diabetic Mellitus (TYPE 1 and TYPE 2) between the ages 30-70 years having ophthalmoscopically detectable Diabetic Retinopathy changes. 3. Patients with history of longer duration of type 1 and type2 Diabetes Mellitus having symptoms of Diabetic Retinopathy will be taken for study. 4. Patients with good glycaemic control will be taken for study. 5. Patients who are fit for yogic therapy are included.

Exclusion criteria

Exclusion criteria: 1. Patients with proliferative Diabetic Retinopathy, and other advanced diabetic eye diseases are excluded. 2. Patients with aided visual acuity less than 6/60 at Snellen’s distant chart. 3. Patients with other type of vascular retinopathies like Hypertensive Retinopathy, Retinopathies of blood dyscrasias, Gestational Diabetic Retinopathy, Retinopathy of prematurity, Sickle cell Retinopathy and Diabetic Maculopathy are excluded. 4. Patients with other systemic diseases like renal disease, Hyperlipidaemia, and Cardiovascular diseases are excluded. 5. Patients who undergone abdominal surgeries, pelvic surgeries and vertebral surgeries and who are having hernia , neck and back injury and pregnant women are excluded.

Design outcomes

Primary

MeasureTime frame
Reduced Microaneurysms, Dot and blot hemorrhages, Hard Exudate, and Cotton wool spots. Visual improvement is seenTimepoint: 12 weeks

Secondary

MeasureTime frame
Diabetic level controlled & Improvement of visionTimepoint: 90 days

Countries

India

Contacts

Public ContactDr Shweta Savalagi

Shri Vijay Mahantesh Ayurvedic Medical College Ilkal

vinu2966@gmail.com8951079943

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026